These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 25172783)
1. Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Xu HB; Shen ZL; Fu J; Xu LZ Phytomedicine; 2014 Sep; 21(11):1221-9. PubMed ID: 25172783 [TBL] [Abstract][Full Text] [Related]
2. Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein. Xu HB; Xu LZ; Mao XP; Fu J Phytomedicine; 2014 Jun; 21(7):1004-9. PubMed ID: 24680616 [TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines. Xu HB; Li L; Liu GQ Chemotherapy; 2011; 57(1):62-70. PubMed ID: 21282948 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
6. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
7. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines. Xu HB; Xu LZ; Li L; Fu J; Mao XP Eur J Pharmacol; 2012 Nov; 694(1-3):39-44. PubMed ID: 22960326 [TBL] [Abstract][Full Text] [Related]
8. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells. Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637 [TBL] [Abstract][Full Text] [Related]
9. 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft. Azab SS; Salama SA; Hassan MH; Khalifa AE; El-Demerdash E; Fouad H; Al-Hendy A; Abdel-Naim AB Cancer Chemother Pharmacol; 2008 Oct; 62(5):893-902. PubMed ID: 18253735 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [TBL] [Abstract][Full Text] [Related]
11. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J; Wang FP; Wei H; Liu G Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274 [TBL] [Abstract][Full Text] [Related]
12. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression. De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517 [TBL] [Abstract][Full Text] [Related]
13. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells. Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439 [TBL] [Abstract][Full Text] [Related]
14. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
15. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway. Chen JM; Bai JY; Yang KX IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742 [TBL] [Abstract][Full Text] [Related]
16. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line. Shaik MS; Chatterjee A; Singh M J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869 [TBL] [Abstract][Full Text] [Related]
17. Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathway. Xu HB; Fu J; Huang F; Yu J Eur J Pharmacol; 2017 May; 803():57-64. PubMed ID: 28342979 [TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Huang M; Jin J; Sun H; Liu GT Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702 [TBL] [Abstract][Full Text] [Related]
19. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue. Chen LM; Liang YJ; Zhang X; Su XD; Dai CL; Wang FP; Yan YY; Tao LY; Fu LW Anticancer Res; 2009 Nov; 29(11):4597-604. PubMed ID: 20032409 [TBL] [Abstract][Full Text] [Related]
20. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo. Ren Y; Wang Y; Zhang Y; Wei D Mol Pharm; 2008; 5(4):579-87. PubMed ID: 18461970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]